[Prevalence, comorbidity and interdisciplinary treatment of rheumatoid arthritis - Insurance data on outpatient and inpatient care in Baden-Württemberg]
- PMID: 28929232
- DOI: 10.1007/s00393-017-0381-6
[Prevalence, comorbidity and interdisciplinary treatment of rheumatoid arthritis - Insurance data on outpatient and inpatient care in Baden-Württemberg]
Abstract
Background: Rheumatoid arthritis (RA) has an increased number of comorbidities compared with the general population.
Objective: Study aim was to collect epidemiological data on prevalence, incidence and comorbidities of RA as well as utilization of outpatient and inpatient care services.
Material and methods: In an age and gender-adjusted case control study, a total of 3.4 million patients insured by the AOK Baden-Württemberg were analysed with respect to visits to physicians, prevalence, incidence and comorbidities of RA. The study was based on out- and inpatient diagnoses from 2013.
Results: The RA prevalence was 0.64% (n = 26,919), the incidence was 0.04%. Patients with RA have significant more comorbidities in almost all diagnosis groups, especially in musculoskeletal and cardiovascular diseases, compared to a control group (n = 181,209). 22.8% of RA patients had not contacted an internist rheumatologist, orthopedist or orthopedic surgeon. Biological disease-modifying anti-rheumatic drugs (DMARDs) were almost exclusively prescribed by internist rheumatologists, while conventional DMARDs were equally prescribed by general practitioners and rheumatologists. Of the RA patients 32.6% were hospitalized at least once a year and were nearly twice as frequently inpatient as the control group.
Conclusion: RA patients need more in- and outpatient healthcare services and suffer significantly more often from comorbidities. The general practitioner is the most frequently visited physician. Other consulted physicians are rheumatologists, ophthalmologists, orthopedists/orthopedic surgeons and internists not specialized in rheumatology. The study highlights the need to create consensus treatment algorithms and maintain a close interdisciplinary and intersectoral cooperation and communication.
Keywords: Comorbidity; Health insurance data; Medical healthcare; Prevalence; Rheumatoid arthritis.
Similar articles
-
[Guideline-Orientated Prescription of Disease-Modifying Drugs in Patients with Rheumatoid Arthritis - an Analysis Based on Social Health Insurance Claims Data].Dtsch Med Wochenschr. 2019 Jun;144(12):e70-e79. doi: 10.1055/a-0759-5202. Epub 2019 Jan 17. Dtsch Med Wochenschr. 2019. PMID: 30654405 German.
-
Comparisons between comorbid conditions and health care consumption in rheumatoid arthritis patients with or without biological disease-modifying anti-rheumatic drugs: a register-based study.BMC Musculoskelet Disord. 2016 Dec 12;17(1):499. doi: 10.1186/s12891-016-1354-7. BMC Musculoskelet Disord. 2016. PMID: 27955647 Free PMC article.
-
Update on the prevalence and incidence of rheumatoid arthritis in Korea and an analysis of medical care and drug utilization.Rheumatol Int. 2018 Apr;38(4):649-656. doi: 10.1007/s00296-017-3925-9. Epub 2018 Jan 4. Rheumatol Int. 2018. PMID: 29302803
-
[Comorbidity in rheumatoid arthritis].Dtsch Med Wochenschr. 2014 Sep;139(37):1844-8. doi: 10.1055/s-0034-1370262. Epub 2014 Sep 2. Dtsch Med Wochenschr. 2014. PMID: 25181002 Review. German.
-
The challenging interplay between rheumatoid arthritis, ageing and comorbidities.BMC Musculoskelet Disord. 2016 Apr 26;17:184. doi: 10.1186/s12891-016-1038-3. BMC Musculoskelet Disord. 2016. PMID: 27118031 Free PMC article. Review.
Cited by
-
Systematic review to estimate the prevalence of inflammatory rheumatic diseases in Germany.Z Rheumatol. 2024 Feb;83(Suppl 1):20-30. doi: 10.1007/s00393-022-01302-5. Epub 2023 Feb 7. Z Rheumatol. 2024. PMID: 36749363 Free PMC article.
-
[Is the prevalence of rheumatoid arthritis truly on the rise?].Z Rheumatol. 2022 May;81(4):323-327. doi: 10.1007/s00393-022-01192-7. Epub 2022 Mar 31. Z Rheumatol. 2022. PMID: 35359174 Free PMC article. German.
-
[Systematic review to estimate the prevalence of inflammatory rheumatic diseases in Germany. German version].Z Rheumatol. 2023 Nov;82(9):727-738. doi: 10.1007/s00393-022-01305-2. Epub 2023 Jan 2. Z Rheumatol. 2023. PMID: 36592211 Free PMC article. German.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical